Go to content

News & Insights

Filters

Changing any of the form inputs will cause the content to refresh with the filtered results.

Skip filters

Acuitas Therapeutics To Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

Read about Acuitas Therapeutics To Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

Acuitas Therapeutics Named Canada’s Top Small and Medium Employers in 2026

Read about Acuitas Therapeutics Named Canada’s Top Small and Medium Employers in 2026

Acuitas Therapeutics’ Lipid Nanoparticle Technology Supports Positive Phase I Data Published by AstraZeneca

Read about Acuitas Therapeutics’ Lipid Nanoparticle Technology Supports Positive Phase I Data Published by AstraZeneca

Acuitas Therapeutics Named Top 100 Global Innovator by LexisNexis for 2026

Read about Acuitas Therapeutics Named Top 100 Global Innovator by LexisNexis for 2026

Acuitas Therapeutics Announces Oral Presentations and Poster Sessions at BioChina and Vaccine Innovation Forum

Read about Acuitas Therapeutics Announces Oral Presentations and Poster Sessions at BioChina and Vaccine Innovation Forum

Acuitas Therapeutics Named One of BC’s Top Employers

Read about Acuitas Therapeutics Named One of BC’s Top Employers

Dr. Ying Tam and Sean Semple Share the New Frontier of Lipid Nanoparticles in mRNA Cancer Vaccines in the European Biopharmaceutical Review

Read about Dr. Ying Tam and Sean Semple Share the New Frontier of Lipid Nanoparticles in mRNA Cancer Vaccines in the European Biopharmaceutical Review

Acuitas Therapeutics Expands Collaboration with RNA Technologies & Therapeutics Through Strategic Investment

Read about Acuitas Therapeutics Expands Collaboration with RNA Technologies & Therapeutics Through Strategic Investment

Acuitas Therapeutics and partners publish comparative study of AAV and mRNA-LNP delivery with in situ sequencing for spatial genome editing 

Read about Acuitas Therapeutics and partners publish comparative study of AAV and mRNA-LNP delivery with in situ sequencing for spatial genome editing 

Acuitas Therapeutics unveils next-generation lipid nanoparticle advancements at the 2025 mRNA Health Conference 

Read about Acuitas Therapeutics unveils next-generation lipid nanoparticle advancements at the 2025 mRNA Health Conference 

Acuitas Therapeutics to showcase LNP delivery platform at four prestigious conferences in November 2025 

Read about Acuitas Therapeutics to showcase LNP delivery platform at four prestigious conferences in November 2025 

Business in Vancouver shines a spotlight on Acuitas Therapeutics in its Life Sciences 2025 feature

Read about Business in Vancouver shines a spotlight on Acuitas Therapeutics in its Life Sciences 2025 feature